Customizable mRNA Synthesis Service
Eurofins Genomics Blue Heron IVT mRNA synthesis service is designed to provide researchers a customizable solution.
Eurofins Genomics Blue Heron in-vitro transcription (IVT) messenger RNA (mRNA) synthesis service is designed to offer a comprehensive solution for researchers seeking high-quality, customizable mRNA synthesis with fast turnaround times. The synthesis service is intended for use in molecular biology, drug discovery, vaccine development, and gene therapy, among other fields.
The IVT mRNA synthesis service is designed to handle various applications and includes customizable mRNA synthesis capabilities to meet specific research needs. Researchers can customize mRNA transcripts in various ways, including modifying the sequence, length, and purity of the mRNA.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
